Correlation Between Emergent Health and Antisense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Emergent Health and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Health and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Health Corp and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Emergent Health and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Health with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Health and Antisense Therapeutics.

Diversification Opportunities for Emergent Health and Antisense Therapeutics

0.61

Correlation Coefficient

Emergent Health  Antisense Therapeutics

Poor diversification

The 3 months correlation between Emergent and Antisense is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Health Corp and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Emergent Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Health Corp are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Emergent Health i.e., Emergent Health and Antisense Therapeutics go up and down completely randomly.

Pair Corralation between Emergent Health and Antisense Therapeutics

Given the investment horizon of 90 days Emergent Health Corp is expected to under-perform the Antisense Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Emergent Health Corp is 2.84 times less risky than Antisense Therapeutics. The pink sheet trades about 0.0 of its potential returns per unit of risk. The Antisense Therapeutics Limited is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1.20  in Antisense Therapeutics Limited on September 25, 2024 and sell it today you would lose (0.20) from holding Antisense Therapeutics Limited or give up 16.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Emergent Health Corp  vs.  Antisense Therapeutics Limited

Emergent Health Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emergent Health Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Emergent Health is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Antisense Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Antisense Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward-looking indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Emergent Health and Antisense Therapeutics

The main advantage of trading using opposite Emergent Health and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Health position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.

The idea behind Emergent Health Corp and Antisense Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.